课题基金 / 基金详情

Refining the Atopic March: Mechanisms of Progression in Black and White Children

Refining the Atopic March: Mechanisms of Progression in Black and White Children
完善特应性游行:黑人和白人儿童的进展机制
批准号:
10260727
负责人:
Gurjit K. Khurana Hershey
金额:
$54.68万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
未结题
起止时间:
2006-07-01 至 2026-06-30

项目摘要

项目成果

Gurjit K. Khurana Hershey的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary For nearly two decades, the “atopic march” concept, which describes the sequential development of atopic dermatitis (AD), food allergy (FA), asthma, and allergic rhinitis (AR) has served as a guiding principle, however, a recent NIH workshop concluded that only about 3% of children follow the traditional atopic march. They stated that while early-life AD remains a major risk factor for the development of any atopic disease, there is no single unique pathway for the atopic march. Rather, there is significant heterogeneity including the timing and organ(s) affected, and the march needs to be revised to include this heterogeneity and incorporate the various combinations. We designed the Mechanisms of Progression of Atopic Dermatitis (AD) to Asthma in CHildren (MPAACH) cohort, the first US prospective longitudinal early life cohort of AD, to meet this need. MPAACH includes 65% Black children and is one of the only early life cohorts that represents this historically underrepresented and understudied population. Previous studies of the atopic march were done mostly in White populations. Our early findings from MPAACH reveal marked racial differences in the atopic march concept and underscore the racial bias in current paradigms around the atopic march. Black children are disproportionately impacted by asthma prevalence, morbidity, and mortality and this race-asthma association is not eliminated after adjusting for socioeconomic factors suggesting that race may also serve as a proxy for a critical biologic factor that we do not currently recognize. Our central hypothesis is that the longitudinal trajectories of sensitization and allergic disease progression are different between Whites and Blacks, and that this is mechanistically due, in part, to biologic differences. We will conduct skin transcriptomics and integrate this data with longitudinal immunologic, environmental, and clinical data to construct the pathogenesis of allergic disease development, progression, persistence, remission, and resolution. Race is a complex concept including sociocultural and socioeconomic, as well as biologic factors. As such, we will define Black and White using self-reported race, genetic ancestry, and biologic methods that quantify melanin content in the skin, thus recognizing the continuum resulting from biologic diversity in addition to the sociocultural definitions of race. This application will have significant public health impact. Through the proposed aims, we will (1) define longitudinal AD phenotypes in Black and White MPAACH children, (2) elucidate skin transcriptomic profiles and biologic pathways that predict AD longitudinal phenotypes for Black and White MPAACH children and (3) define longitudinal immunophenotypes of AD in Black and White children and construct the pathogenesis of allergic disease by race based on genetics (from Project 2)--> skin transcriptomics--> immunologic milieu--> longitudinal clinical endotypes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Medical Scientist Training Program
  • 批准号:
    10620999
  • 项目类别:
  • 资助金额:
    $92.89万
  • 财政年份:
    2023
  • 负责人:
    Gurjit K. Khurana Hershey
  • 依托单位:
Multi-omics of the Frequent Exacerbator Asthmatic
  • 批准号:
    10197294
  • 项目类别:
  • 资助金额:
    $45.2万
  • 财政年份:
    2021
  • 负责人:
    Gurjit K. Khurana Hershey
  • 依托单位:
Multi-omics of the Frequent Exacerbator Asthmatic
  • 批准号:
    10596089
  • 项目类别:
  • 资助金额:
    $45.2万
  • 财政年份:
    2021
  • 负责人:
    Gurjit K. Khurana Hershey
  • 依托单位:
Multi-omics of the Frequent Exacerbator Asthmatic
  • 批准号:
    10390405
  • 项目类别:
  • 资助金额:
    $45.2万
  • 财政年份:
    2021
  • 负责人:
    Gurjit K. Khurana Hershey
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: